Pharmaco-proteomic Platform to Evaluate Drug Interactions in Liver Transplant Patients
Recruiting
Observational Study
Drug-drug Interaction
Liver Transplantation
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 48 (estimated)
- Sponsor
- Pontificia Universidad Catolica de Chile · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to enhance the ability to forecast kidney failure in liver transplant patients in the ICU under multidrug treatment by developing a computer platform that integrates mathematical models of drug interactions, proteomics, and clinical data. The main outcomes it aims to develop are:
1. Design the multidrug web computing platform with available information on d…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Liver transplant patients undergoing surgery at UC Christus Hospital
Exclusion Criteria:
* Patients on renal replacement therapy
* Patients for whom no clinical or pharmacological registry is available
Contacts